REXAHN PHARMACEUTICALS INC's ticker is RNN and the CUSIP is 761640200. A total of 25 filers reported holding REXAHN PHARMACEUTICALS INC in Q1 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $8,000 | -42.9% | 15,000 | 0.0% | 0.00% | -50.0% |
| Q4 2018 | $14,000 | -33.3% | 15,000 | 0.0% | 0.00% | -66.7% |
| Q2 2018 | $21,000 | -4.5% | 15,000 | 0.0% | 0.01% | -14.3% |
| Q1 2018 | $22,000 | -26.7% | 15,000 | 0.0% | 0.01% | -30.0% |
| Q4 2017 | $30,000 | -16.7% | 15,000 | 0.0% | 0.01% | -23.1% |
| Q3 2017 | $36,000 | -16.3% | 15,000 | 0.0% | 0.01% | -23.5% |
| Q2 2017 | $43,000 | – | 15,000 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|